Ultralife (ULBI) Equity Average (2011 - 2026)

Ultralife's Equity Average history runs 16 years deep, the most recent figure standing at $129.9 million for Q1 2026.

• In Q1 2026, Equity Average fell 4.07% year-over-year to $129.9 million; the TTM figure through Mar 2026 stood at $129.9 million (down 4.07% YoY), while the FY2025 annual figure was $132.2 million, up 1.81% from the prior year.
• Equity Average was $129.9 million for Q1 2026 at Ultralife, down from $133.8 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $138.0 million in Q3 2025 to a low of $115.8 million in Q4 2022.
• Historically, Equity Average has averaged $126.3 million across 5 years, with a median of $127.2 million in 2024.
• The sharpest annual moves came in 2024 and 2026: Equity Average advanced 11.1% in 2024, then fell 4.07% in 2026.
• A 5-year view of Equity Average shows it stood at $115.8 million in 2022, then gained by 6.68% to $123.5 million in 2023, then rose by 8.8% to $134.4 million in 2024, then retreated by 0.46% to $133.8 million in 2025, then slipped by 2.92% to $129.9 million in 2026.
• The last three Equity Average figures came in at $129.9 million (Q1 2026), $133.8 million (Q4 2025), and $138.0 million (Q3 2025), per Business Quant data.